Zepp Health Corporation American depositary shares, each representing sixteen - ZEPP STOCK NEWS

Zepp Health (NYSE: ZEPP) has scheduled its third quarter 2024 financial results announcement for November 18, 2024, after market close. The company will host a conference call at 8:30 p.m. Eastern Time on the same day. The earnings call will be accessible via phone and webcast, with dial-in numbers provided for US, International, Mainland China, and Hong Kong participants. A replay of the conference call will be available until November 25, 2024.

Zepp Health has launched the enhanced Zepp App 9, designed to provide a more personalized health and wellness experience for Amazfit users. The update features a streamlined interface with color-coded statistics, enhanced smart analytics, and real-time data analysis. Key additions include a daily personalized exertion score, heart health dashboard, and Zepp Aura Premium Service for advanced sleep insights. The app offers mini-apps, watch faces, and third-party integrations with platforms like Strava and adidas Running. Data protection is ensured through AWS storage and GDPR compliance.

Zepp Health (NYSE: ZEPP), a global leader in smart wearables and health technology, has regained compliance with the New York Stock Exchange's (NYSE) continued listing criterion of a minimum share price. The company received a letter from the NYSE on October 2, 2024, confirming its compliance with Section 802.01C of the NYSE Listed Company Manual.

This development follows a previous notification from the NYSE on April 30, 2024, which informed Zepp Health that it had fallen below compliance standards due to its American depositary shares' average closing price being less than $1.00 for a consecutive 30 trading-day period. With this new confirmation, Zepp Health is no longer considered below the NYSE Minimum Price Continued Listing Criterion.

Amazfit, a smart wearable brand by Zepp Health (NYSE: ZEPP), has announced HYROX world champions Meg Jacoby and Hunter McIntyre as new brand ambassadors. This follows Amazfit's recent appointment as the Official Wearable Partner & Timekeeper of HYROX, the World Series of Fitness Racing. Jacoby, who made history by completing a HYROX race in under one hour, uses the Amazfit Cheetah Pro smartwatch. McIntyre, a three-time HYROX world champion, relies on the Amazfit T-Rex series.

Amazfit's smartwatches offer advanced features including industry-leading GPS, AI-driven training programs, and the Readiness feature for recovery insights. The partnership aims to expand Amazfit's presence in the endurance sector and drive product innovation through collaboration with elite athletes.

Zepp Health (NYSE: ZEPP) has announced a change in its American Depositary Shares (ADS) ratio from 1:4 to 1:16, effective around September 16, 2024. This change will have the same effect as a one-for-four reverse ADS split. ADS holders will need to exchange every four existing ADSs for one new ADS. The company's underlying Class A ordinary shares will not be affected, and no new shares will be issued or cancelled. Zepp Health will continue trading on the NYSE under the ticker 'ZEPP'. While the ADS trading price is expected to increase proportionately, the company cannot guarantee that it will be equal to or greater than four times the previous price.

Amazfit, a brand under Zepp Health (NYSE: ZEPP), unveiled the Amazfit T-Rex 3 smartwatch at IFA Berlin. This new model combines military-grade durability with advanced features for everyday adventurers. Key highlights include:

- 16% larger and 100% brighter AMOLED display
- Up to 27 days battery life with typical usage
- Over 170 workout modes
- Enhanced privacy protection measures
- Zepp OS 4 with integrated AI and GPT-4o technology
- Zepp Pay for contactless payments in 31 European countries

The T-Rex 3 is designed for both extreme outdoor conditions and indoor workouts, featuring advanced map and workout data visibility. Pricing starts from $279.99 USD or €299.90 Euro, with availability through official Amazfit channels and retail partners.

Zepp Health (NYSE: ZEPP) has announced significant changes to its Board of Directors, effective September 1, 2024. The company has appointed three new directors: Mr. Alain Lam (CFO of Xiaomi Group), Mr. Mike Yan Yeung (COO of Zepp Health), and Mr. Meihui Fan (CTO of Zepp Health). Simultaneously, Mr. De Liu, Ms. Yunfen Lu, and Mr. Xiaojun Zhang have resigned from the Board.

The new appointments bring extensive experience in finance, technology, and corporate governance to Zepp Health's leadership. The company expects these changes to contribute valuable expertise to its ongoing development in the smart wearables and health technology sectors.

Zepp Health's Amazfit has been named the Official Wearable Partner & Timekeeper of HYROX, the World Series of Fitness Racing, in a two-year partnership. Amazfit will provide smartwatches and the Helio Ring to support HYROX athletes, offering 24/7 health and fitness monitoring. The partnership includes:

1. Physical activation at HYROX events with live experiences and consumer shops
2. Software updates for Amazfit smartwatches with a HYROX race mode
3. Integration into HYROX365 for Training Clubs and Coaches
4. Comprehensive data insights for athletes' recovery and performance optimization
5. AI-powered Zepp Coach for personalized training plans

This collaboration aims to enhance the fitness racing experience and support athletes in reaching their peak performance.

Zepp Health (NYSE: ZEPP) reported its Q2 2024 unaudited financial results.

Revenue was US$40.6 million, a 56% decrease YoY. The net loss was US$10.8 million, with a basic and diluted net loss of US$0.04 per share and US$0.17 per ADS. Gross margin reached a record-high of 40.3%, compared to 22.0% in Q2 2023, driven by self-branded products.

R&D expenses decreased by 15.3% YoY to US$10.8 million, while S&M expenses rose by 3.3% to US$10.6 million. G&A expenses dropped by 37.2% to US$4.9 million. Total units shipped fell by 65.8% YoY to 1.3 million.

Outlook for Q3 2024 expects revenue between US$45 million and US$60 million, indicating 18% to 59% growth in self-branded product revenue compared to Q2 2024.